Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...

Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...

We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...

Tempus AI Inc (NASDAQ:TEM) shares are trading lower Tuesday after the company reported mixed fourth-quarter financial results ...

Tempus AI Inc (TEM) reports impressive revenue growth, strategic acquisitions, and extended partnerships, setting the stage for a promising 2025.

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...

At this time, I would like to welcome everyone to the Tempus fourth-quarter 2024 financial results conference call. Thank you, Jason. Good afternoon and welcome to Tempus fourth-quarter 2024 ...

Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...

Tempus announced its acquisition of Ambry Genetics at closing in November and the deal closed earlier this month.

Tempus AI (TEM) plunged Tuesday as its quarterly revenues missed expectations, days after insiders were reported as offloading the stock in big ...

Tempus AI (TEM) stock dropped 19% Tuesday, the day after the company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast. Read more here.

We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other AI stocks in ...